Early Infantile Epileptic Encephalopathy
Symptoms, Doctors, Treatments, Advances & More

Early Infantile Epileptic Encephalopathy Overview

Save information for later
Sign Up

Learn About Early Infantile Epileptic Encephalopathy

What is the definition of Early Infantile Epileptic Encephalopathy?
Early Infantile Epileptic Encephalopathy (EIEE) is a neurological disorder characterized by seizures. The disorder affects newborns, usually within the first three months of life in the form of epileptic seizures. Infants may have primarily tonic seizures (which cause stiffening of muscles of the body, generally those in the back, legs, and arms), but may also experience partial seizures, and rarely, myoclonic seizures (which cause jerks or twitches of the upper body, arms, or legs). Most infants with the disorder show underdevelopment of part or all of the cerebral hemispheres or structural anomalies. Some cases are caused by metabolic disorders or by genetic changes in several different genes. The cause for many cases can't be determined.
What are the alternative names for Early Infantile Epileptic Encephalopathy?
  • Early Infantile Epileptic Encephalopathy
Who are the top Early Infantile Epileptic Encephalopathy Local Doctors?
Elite in Early Infantile Epileptic Encephalopathy
Elite in Early Infantile Epileptic Encephalopathy
Referral may be required

UCL Queen Square Institute Of Neurology

London, ENG, GB 

Reza Maroofian practices practicing medicine in London, United Kingdom. Mr. Maroofian is rated as an Elite expert by MediFind in the treatment of Early Infantile Epileptic Encephalopathy. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Early Infantile Epileptic Encephalopathy, Achalasia Microcephaly Syndrome, Microcephaly, Cortical Dysplasia, and Deep Brain Stimulation.

Elite in Early Infantile Epileptic Encephalopathy
Dr. Fowzan S. Alkuraya
Pediatrics | Medical Genetics
Elite in Early Infantile Epileptic Encephalopathy
Dr. Fowzan S. Alkuraya
Pediatrics | Medical Genetics
Referral may be required
300 Longwood Ave, Fegan 10, 
Boston, MA 
617-355-6000
Languages Spoken:
English

Fowzan Alkuraya is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Boston, Massachusetts. Dr. Alkuraya is rated as an Elite provider by MediFind in the treatment of Early Infantile Epileptic Encephalopathy. He is also highly rated in 71 other conditions, according to our data. His clinical expertise encompasses Achalasia Microcephaly Syndrome, Microcephaly, Early Infantile Epileptic Encephalopathy, Cortical Dysplasia, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Early Infantile Epileptic Encephalopathy
Elite in Early Infantile Epileptic Encephalopathy
Referral may be required
Rome, IT 

Nicola Specchio practices practicing medicine in Rome, Italy. Ms. Specchio is rated as an Elite expert by MediFind in the treatment of Early Infantile Epileptic Encephalopathy. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Epilepsy, Myoclonic Epilepsy, CLN2 Disease, Seizures, and Deep Brain Stimulation.

View All Doctors
What are the latest Early Infantile Epileptic Encephalopathy Clinical Trials?
Investigations of Individuals With MEHMO Syndrome or eIF2-Pathway Related Conditions
Investigations of Individuals With MEHMO Syndrome or eIF2-Pathway Related Conditions
Enrollment Status: Recruiting
Publish Date: April 27, 2026

Summary: This observational natural history study will follow individuals with MEHMO (Mental disability, Epileptic seizure, Hypopituitarism/Hypogenitalism, Microcephaly, Obesity) syndrome or an eIF2-pathway related disorder, who have symptoms such as intellectual delay, seizures, abnormal hormone and blood sugar levels, and decreased motor skills. No current treatment for these conditions is available. A m...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center